During the last session, Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares were 0.62 million, with the beta value of the company hitting 0.00. At the end
Xilio Therapeutics Inc (NASDAQ:XLO)’s traded shares stood at 0.37 million during the last session, with the company’s beta value hitting -0.03. At the close of
Xilio Therapeutics Inc (NASDAQ:XLO) has a beta value of -0.06 and has seen 2.02 million shares traded in the last trading session. The company, currently
In the last trading session, 0.23 million shares of the Xilio Therapeutics Inc (NASDAQ:XLO) were traded, and its beta was -0.14. Most recently the company’s
In last trading session, Xilio Therapeutics Inc (NASDAQ:XLO) saw 1.0 million shares changing hands with its beta currently measuring -0.15. Company’s recent per share price
Xilio Therapeutics Inc (NASDAQ:XLO) has a beta value of -0.24 and has seen 2.94 million shares traded in the last trading session. The company, currently
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne